Skip to main content

2022 Midyear Clinical Meeting & Exhibition Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

170 Views

Resident Posters

(13-254) Assessing the Financial Toxicity Among Early Triple Negative Breast Cancer Patients Treated with Pembrolizumab Plus Chemotherapy: A Cost-Effectiveness Analysis

Wednesday, December 7, 2022

3:15 PM – 4:15 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Maya Leiva, Andrea Lee

Primary Author(s)

Carolynne Yen, n/a
Virginia